Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy

World Journal of Gastroenterology : WJG
Siamak M SerajJames M Richter

Abstract

To reduce readmissions and improve patient outcomes in cirrhotic patients through better understanding of readmission predictors. We performed a single-center retrospective study of patients admitted with decompensated cirrhosis from January 1, 2011 to December 31, 2013 (n = 222). Primary outcomes were time to first readmission and 30-d readmission rate due to complications of cirrhosis. Clinical and demographic data were collected to help describe predictors of readmission, along with care coordination measures such as post-discharge status and outpatient follow-up. Univariate and multivariate analyses were performed to describe variables associated with readmission. One hundred thirty-two patients (59.4%) were readmitted at least once during the study period. Median time to first and second readmissions were 54 and 93 d, respectively. Thirty and 90-d readmission rates were 20.7 and 30.1 percent, respectively. Predictors of 30-d readmission included education level, hepatic encephalopathy at index, ALT more than upper normal limit and Medicare coverage. There were no statistically significant differences in readmission rates when stratified by discharge disposition, outpatient follow-up provider or time to first outpatient vis...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Dec 4, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E J BiniT Komorowski
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W Ray KimHashem El-Serag
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patrick S KamathUNKNOWN Advanced Liver Disease Study Group
May 24, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Charmaine A StewartPatrick S Kamath
Sep 19, 2008·The New England Journal of Medicine·Elliott S Fisher
Apr 3, 2009·The New England Journal of Medicine·Stephen F JencksEric A Coleman
Feb 27, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Peter JepsenHendrik Vilstrup
Nov 26, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kenneth BermanNaga Chalasani
Sep 21, 2011·The American Journal of Gastroenterology·Michael L VolkAnna S Lok
May 31, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Maria StepanovaZobair M Younossi
Apr 16, 2013·Gastroenterology·Sumeet K AsraniW Ray Kim
Aug 31, 2013·Digestive Diseases and Sciences·Kara B JohnsonRaymond T Chung
May 23, 2015·International Journal of General Medicine·Sammy Saab
Sep 24, 2015·Digestive Diseases and Sciences·Bruce Runyon, Lavinia Mitroi
Sep 27, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elliot B TapperMichelle Lai
Nov 6, 2015·Southern Medical Journal·Kriti AgrawalSangeeta Agrawal
Dec 23, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jasmohan S BajajUNKNOWN North American Consortium for the Study of End-Stage Liver Disease
Mar 19, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fasiha KanwalHashem B El-Serag
Apr 18, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elliot B TapperJessica Mellinger

❮ Previous
Next ❯

Citations

Mar 31, 2018·Journal of Gastroenterology and Hepatology·Parul TandonErin Kelly
Jan 29, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Abdel-Aziz ShaheenMark G Swain
Jul 3, 2019·Journal of Gastroenterology and Hepatology·Kishan P PatelSomashekar G Krishna
May 16, 2019·Journal of General Internal Medicine·Jordan Sack, Nikroo Hashemi
Jun 11, 2019·The American Journal of Gastroenterology·Russell RosenblattArun Jesudian
Sep 3, 2020·JMIR Medical Informatics·Patricia BloomJames M Richter
Mar 3, 2020·Euroasian Journal of Hepato-gastroenterology·Anurag LavekarPradeep T Satyanarayana
May 22, 2021·Digestive Diseases and Sciences·Patricia P BloomJames M Richter
Jun 16, 2021·Neurochemical Research·Rafael Ochoa-SanchezChristopher F Rose
Jun 26, 2021·Digestive Diseases and Sciences·Catherine T FrenetteSammy Saab
Jan 10, 2022·Archives of Physical Medicine and Rehabilitation·Tomohiko KamoKeisuke Suzuki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.